Nanocarriers for Mycobacterium Tuberculosis

Tuberculosis (TB) is considered as one of the biggest threats to the global health and one of the major reasons for death worldwide. It is considered to be caused by bacteria which are susceptible to drugs and its treatment is a lengthy process requiring a minimum of six months of medication. Subsequently, this results in incomplete treatment of the patient. One of the newly adopted Sustainable Development Goals by WHO is to end this TB epidemic by 2030. Nanoparticle technology helps to reduce the duration of treatment and helps in effective delivery of the drugs. This review article aims to highlight effective and the multiple advantages of nanoparticles in drug delivery of tuberculosis.